2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$44.48$0.00 (0.00%)
Price as of Jun 23, 2026 5:39 PM EDT- $2.6BMarket Cap
- 39.04%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$44.48$0.00 (0.00%)
SUPN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $44.48 | ||
Change | +$0.10 (+0.23%) | ||
Open | $44.69 | ||
High | $45.50 | ||
Low | $44.44 | ||
Previous Close | $44.48 | ||
Volume | 544,634 | ||
30-Day Average Volume | 630,380 | ||
1-Week Change | 1.41% | ||
1-Month Change | -7.74% | ||
1-Year Change | 39.04% | ||
3-Year Change | 32.66% | ||
5-Year Change | 36.86% | ||
Fundamentals | |||
Shares Outstanding | 58.0M | ||
Total Assets | $1.5B | ||
Market Cap | $2.6B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $150.8M | ||
Net Income | -$2.3M | ||
Free Cash Flow | $66.5M | ||
EBIT | -$6.0M | ||
EBITDA | $20.2M | ||
Net Working Capital | $357.7M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | 119 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 2 | ||
P/E | -1,112 | ||
PEG | -25 | ||
Price/Free Cash Flow | 39 | ||
Price/Operating Cash Flow | 39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue